APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,731 | -77.6% | 47,668 | -0.8% | 0.00% | – |
| Q2 2023 | $70,147 | -28.3% | 48,046 | 0.0% | 0.00% | – |
| Q1 2023 | $97,773 | -12.3% | 48,046 | 0.0% | 0.00% | – |
| Q4 2022 | $111,467 | -23.7% | 48,046 | 0.0% | 0.00% | – |
| Q3 2022 | $146,000 | -15.1% | 48,046 | 0.0% | 0.00% | – |
| Q2 2022 | $172,000 | -46.1% | 48,046 | -11.6% | 0.00% | – |
| Q1 2022 | $319,000 | -25.8% | 54,367 | -0.6% | 0.00% | – |
| Q4 2021 | $430,000 | -49.8% | 54,673 | -1.3% | 0.00% | – |
| Q3 2021 | $856,000 | -29.8% | 55,394 | +1.9% | 0.00% | – |
| Q2 2021 | $1,219,000 | -30.7% | 54,384 | -5.6% | 0.00% | – |
| Q1 2021 | $1,759,000 | -17.5% | 57,605 | -1.0% | 0.00% | – |
| Q4 2020 | $2,132,000 | +1184.3% | 58,168 | +166.8% | 0.00% | – |
| Q3 2020 | $166,000 | -8.8% | 21,805 | 0.0% | 0.00% | – |
| Q2 2020 | $182,000 | +124.7% | 21,805 | -0.7% | 0.00% | – |
| Q1 2020 | $81,000 | – | 21,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $64,504,000 | 9.85% |
| Stonepine Capital Management, LLC | 18,280 | $670,000 | 0.51% |
| Ghost Tree Capital, LLC | 50,000 | $1,833,000 | 0.41% |
| Anson Funds Management LP | 45,462 | $1,666,000 | 0.34% |
| RTW INVESTMENTS, LP | 288,236 | $10,564,000 | 0.18% |
| Dynamic Technology Lab Private Ltd | 13,202 | $484,000 | 0.08% |
| Alyeska Investment Group, L.P. | 49,601 | $1,818,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11,493 | $421,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 8,203 | $301,000 | 0.01% |
| Renaissance Technologies | 254,423 | $9,325,000 | 0.01% |